Geode Capital Management, LLC Vir Biotechnology, Inc. Transaction History

Geode Capital Management, LLC

  • $1.21 Trillion
  • Q3 2024

A detailed history of Geode Capital Management, LLC transactions in Vir Biotechnology, Inc. stock. As of the latest transaction made, Geode Capital Management, LLC holds 2,188,774 shares of VIR stock, worth $16.1 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,188,774
Previous 2,183,628 0.24%
Holding current value
$16.1 Million
Previous $19.4 Million 15.65%
% of portfolio
0.0%
Previous 0.0%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024
BUY
$7.26 - $10.7 $37,359 - $55,062
5,146 Added 0.24%
2,188,774 $16.4 Million
Q2 2024

Aug 09, 2024
BUY
$7.63 - $12.66 $1.79 Million - $2.97 Million
234,439 Added 12.03%
2,183,628 $19.4 Million
Q1 2024

May 13, 2024
BUY
$8.6 - $11.9 $540,019 - $747,236
62,793 Added 3.33%
1,949,189 $19.7 Million
Q4 2023

Feb 13, 2024
BUY
$7.76 - $10.29 $718,048 - $952,154
92,532 Added 5.16%
1,886,396 $19 Million
Q3 2023

Nov 13, 2023
BUY
$9.14 - $24.62 $942,215 - $2.54 Million
103,087 Added 6.1%
1,793,864 $16.8 Million
Q2 2023

Aug 11, 2023
BUY
$23.2 - $27.29 $3.84 Million - $4.51 Million
165,359 Added 10.84%
1,690,777 $41.5 Million
Q1 2023

May 15, 2023
BUY
$22.26 - $30.85 $1.32 Million - $1.82 Million
59,140 Added 4.03%
1,525,418 $35.5 Million
Q4 2022

Feb 13, 2023
BUY
$19.96 - $28.22 $998,978 - $1.41 Million
50,049 Added 3.53%
1,466,278 $37.1 Million
Q3 2022

Nov 14, 2022
BUY
$18.26 - $31.1 $682,193 - $1.16 Million
37,360 Added 2.71%
1,416,229 $27.3 Million
Q2 2022

Aug 12, 2022
BUY
$19.08 - $26.7 $2.55 Million - $3.56 Million
133,478 Added 10.72%
1,378,869 $35.1 Million
Q1 2022

May 13, 2022
BUY
$21.19 - $40.01 $287,569 - $542,975
13,571 Added 1.1%
1,245,391 $32 Million
Q4 2021

Feb 11, 2022
BUY
$30.97 - $54.03 $1.12 Million - $1.95 Million
36,062 Added 3.02%
1,231,820 $51.6 Million
Q3 2021

Nov 12, 2021
BUY
$34.9 - $54.54 $991,788 - $1.55 Million
28,418 Added 2.43%
1,195,758 $52 Million
Q2 2021

Aug 13, 2021
BUY
$38.75 - $51.0 $3.48 Million - $4.59 Million
89,918 Added 8.35%
1,167,340 $55.2 Million
Q1 2021

May 12, 2021
BUY
$26.34 - $83.07 $2.92 Million - $9.22 Million
111,047 Added 11.49%
1,077,422 $55.2 Million
Q4 2020

Feb 12, 2021
BUY
$25.51 - $43.38 $1.33 Million - $2.26 Million
52,065 Added 5.69%
966,375 $25.9 Million
Q3 2020

Nov 13, 2020
BUY
$28.28 - $53.6 $14.8 Million - $28.1 Million
524,887 Added 134.79%
914,310 $31.4 Million
Q2 2020

Aug 13, 2020
BUY
$27.89 - $47.86 $7.62 Million - $13.1 Million
273,143 Added 234.9%
389,423 $16 Million
Q1 2020

May 14, 2020
BUY
$12.04 - $60.2 $975,252 - $4.88 Million
81,001 Added 229.6%
116,280 $3.98 Million
Q4 2019

Feb 13, 2020
BUY
$11.83 - $15.85 $417,350 - $559,172
35,279 New
35,279 $443,000

Others Institutions Holding VIR

# of Institutions
219
Shares Held
87.4M
Call Options Held
127K
Put Options Held
1.19M
View Full List

About Vir Biotechnology, Inc.

VIR Quotes by TradingView
  • Ticker VIR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 132,638,000
  • Market Cap $975M
  • Description
  • Vir Biotechnology, Inc., a commercial-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. It develops Sotrovimab (VIR-7832), a SARS-CoV-2-neutralizing mAbs to treat and prevent COVID-19 infection under the Xevudy brand; VIR-2218 and VIR-3434 for the treatment of hepatitis B virus; VIR-2482 fo...
More about VIR
Track This Portfolio

Track Geode Capital Management, LLC Portfolio

Follow Geode Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email